AI assistant
EBOS GROUP LIMITED — Director's Dealing 2023
Mar 21, 2023
64813_rns_2023-03-21_ad8719b9-07c0-4d92-9f6a-75dc01736f45.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 35] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Mar-23 | |
| Date of last disclosure: | 31-Jan-22 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | ElizabethCoutts | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | ||
| Position held in listed issuer: | Director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinary shares Nature of the affected relevant interest(s): Issue of shares pursuant to dividend reinvestmentplan For that relevant interest- Number held in class before acquisition or disposal: 35,323 Number held in class after acquisition or disposal: 35,748 Current registered holder(s): N/A Registered holder(s) once transfers are registered: Como Nominees Limited Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) Type of affected derivative: Class of underlyingfinancialproducts: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): A statement as to whether the derivative is cash settled orphysicallysettled: |
||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
||
| For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
||
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | 1 | |
| 17-Mar-23 | ||
| Issue of shares pursuant to dividend reinvestmentplan |
||
| N/A |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
$18,700.00 | |
|---|---|---|
| Numberof financialproducts towhichthe transaction related: | 425 ordinary shares | |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | |
| Date of theprior written clearance(if any): | N/A |
Summary of other relevant interests after acquisition or disposal:
| Summary of other relevant interests after acquisition or disposal: | |||
|---|---|---|---|
| Class ofquotedfinancialproducts: | Ordinary shares | ||
| Nature of relevantinterest: | Non-beneficial interest | ||
| _For that relevant interest,- _ | |||
| Number heldinclass: | 71592ordinary shares | ||
| Elizabeth Mary Coutts & | |||
| John Matthew Cullity as | |||
| trustees of the EBOS Staff | |||
| Currentregisteredholder(s): | Share Plan | ||
| For a derivative relevant interest,- | |||
| Type ofderivative: | |||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial | |||
| products (if any): | |||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable | |||
| under the derivative or the value of the derivative is affected by the value of the | |||
| underlyingfinancialproducts: | |||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | |||
| interest in the derivative: |
Certification
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
|---|---|---|
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 22-Mar-23 | |
| Name and title of authorised person: | Janelle Cain, General Counsel EBOS Group Limited |
|
==> picture [98 x 35] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Mar-23 | |
| Date of last disclosure: | 6-Oct-22 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Stuart McLauchlan | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Director | |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | Ordinaryshares | |
|---|---|---|
| Nature of the affected relevant interest(s): | Issue of shares pursuant to dividend reinvestmentplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 2,385 | |
| Number held in class after acquisition or disposal: | 2,414 | |
| Current registered holder(s): | N/A | |
| Registered holder(s)once transfers are registered: | JBWere(NZ)Nominees Limited |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
| Details of transactions giving rise to acquisition or disposal | ||
|---|---|---|
| Total numberoftransactions towhich noticerelates: | 1 | |
| Details of transactions requiring disclosure- | ||
| Date oftransaction: | 17-Mar-23 | |
| Issue of shares pursuant to dividend | ||
| Nature of transaction: | reinvestmentplan | |
| Name ofany otherparty orparties to the transaction(if known): | N/A |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
$1,276.00 | $1,276.00 | |
|---|---|---|---|
| Numberof financialproducts towhichthe transaction related: | 29 ordinaryshares | ||
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
|||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | ||
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevantinterest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,- |
|||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
| Certification | ||
|---|---|---|
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 22-Mar-23 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|
==> picture [98 x 35] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Mar-23 | |
| Date of last disclosure: | 6-Oct-22 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | SarahOttrey | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Director | |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | Ordinary shares | |
|---|---|---|
| Nature of the affected relevant interest(s): | Issue of shares pursuant to dividend reinvestmentplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 1. 9742 ordinary shares 2. 3469 ordinaryshares |
|
| Number held in class after acquisition or disposal: | 1. 9828 ordinary shares 2. 3469 ordinaryshares |
|
| Current registered holder(s): | N/A | |
| Registered holder(s) once transfers are registered: | 1. Sarah Christine Ottrey & Peter Calder Groves 2. FNZ Nominees Limited which holds shares on behalf of The Phil Ingham FamilyTrust |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
| Details of transactions requiring disclosure- | ||
|---|---|---|
| Date oftransaction: | 17-Mar-23 | |
| Nature of transaction: | Issue of shares pursuant to dividend reinvestmentplan |
|
| Name ofany otherparty orparties to the transaction(if known): | N/A | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
1. $3,784.00 2. N/A |
|
| Numberof financialproducts towhichthe transaction related: | 1. 86 ordinary shares 2. N/A |
|
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | |
| Date of theprior written clearance(if any): | N/A |
Summary of other relevant interests after acquisition or disposal:
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
|---|---|---|---|
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
|||
| Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person: |
22-Mar-23 Janelle Cain, General Counsel, EBOS Group Limited |
||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | 22-Mar-23 | ||
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Mar-23 | |
| Date of last disclosure: | 6-Oct-22 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | LeonardHansen | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief FinancialOfficer | |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | Ordinary shares | |
|---|---|---|
| Nature of the affected relevant interest(s): | Issue of shares pursuant to dividend reinvestmentplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 1,486 | |
| Number held in class after acquisition or disposal: | 1,499 | |
| Current registered holder(s): | N/A | |
| Registered holder(s) once transfers are registered: | Leonard Hansen |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
| Details of transactions giving rise to acquisition or disposal | ||
|---|---|---|
| Total numberoftransactions towhich noticerelates: | 1 | |
| 17-Mar-23 | ||
| Issue of shares pursuant to dividend reinvestmentplan |
||
| N/A |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
$572.00 | |
|---|---|---|
| Numberof financialproducts towhichthe transaction related: | 13 ordinary shares | |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | |
| Date of theprior written clearance(if any): | N/A |
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Certification
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
|---|---|---|
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 22-Mar-23 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|